Novavax Stock (NASDAQ: NVAX) stock price, news, charts, stock research, profile.
Open | $9.690 |
Close | $13.110 |
Volume / Avg. | 123.508M / 9.413M |
Day Range | 9.520 - 13.970 |
52 Wk Range | 3.532 - 11.000 |
Market Cap | $1.831B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 92 |
Short Interest | 40.28% |
Days to Cover | 11.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Novavax (NASDAQ: NVAX) through any online brokerage.
Other companies in Novavax’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA) and Immatics (NASDAQ:IMTX).
The latest price target for Novavax (NASDAQ: NVAX) was reported by TD Cowen on Monday, May 13, 2024. The analyst firm set a price target for 10.00 expecting NVAX to fall to within 12 months (a possible -23.31% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Novavax (NASDAQ: NVAX) is $13.04 last updated May 13, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Novavax.
Novavax’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.